CardiologyBeginner

HAS-BLED Score

Assesses bleeding risk in patients on anticoagulation therapy.

Clinical Parameters

8 Variables

Awaiting Clinical Parameters

Configure the patient variables on the left and select Calculate Result to generate the clinical score and stratification.

Verified 2026 GuidelinesInstant Calculation
Jump to Formula & Clinical Protocol ↓
Advertisement
High Yield Prometric TopicCardiology

Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)

Clinical calculations and diagnostic scoring systems like HAS-BLED Score frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.

Clinical Significance & Diagnostic Standard
2026 Clinical Reference

What is the HAS-BLED Score?

📋Clinical Summary & Definition Capsule

The HAS-BLED Score is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in cardiology practice. The HAS-BLED score is a clinical prediction tool used to estimate the risk of major bleeding in patients with atrial fibrillation who are receiving anticoagulant therapy. It helps clinicians identify modifiable risk factors and balance bleeding risk against thromboembolic risk. Clinical scoring tools like HAS-BLED Score are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).

💡Clinical Pearls & Diagnostic Utility

A high HAS-BLED score should not be used as a reason to withhold anticoagulation in AF patients at risk of stroke, but rather to address modifiable risk factors and ensure regular monitoring.

Mathematical Formulation

Formula & Calculation Parameters

The mathematical equation and clinical variables required to calculate HAS-BLED Score:

Sum of points for each present risk factor (max 9)
Risk Stratification

Score Interpretation & Clinical Stratification

Score RangeClinical InterpretationRisk Tier
≤ 0Low Riskgreen
1 – 2Moderate Riskyellow
≥ 3High Riskred
Normal Values / Reference Standard: Score of 0–2 is generally considered low-to-moderate risk; ≥3 indicates high risk of major bleeding.
Clinical Limitations & Contraindications

When to Exercise Caution

Does not predict absolute bleeding risk over time; does not account for all possible bleeding risk factors (e.g., genetic factors, frailty). Clinical judgment remains essential.

Sponsored Content
Medical Review & Guidelines Compliance
MD

Clinical Review Board

Dr. Muhammad Nouman, MBBS

Capital Medical University | PMDC Reg No: 117744-P

Clinical Audit Status

✓ Verified for 2026 Guidelines

Last updated: 2026-09-11

Peer-Reviewed Medical Literature

  • Pisters R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093-1100.
  • Camm AJ, et al. 2012 Focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2012;33(21):2719-2747.
Advertisement